Freeman R, Wieling W, Axelrod FB, et al.; Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69-72.
Freeman R, Abuzinadah AR, Gibbons C, et al.; Orthostatic hypotension: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72(11):1294-1309.
Juraschek SP, Daya N, Appel LJ, et al.; Orthostatic hypotension in middle- age and risk of falls. Am J Hypertens. 2017;30(2):188-195.
Lei LY, Chew DS, Raj SR. Differential diagnosis of orthostatic hypotension. Auton Neurosci. 2020;228:102713.
Rutan GH, Hermanson B, Bild DE, et al.; Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension. 1992;19(6 pt 1):508-519.
Farrell MC, Shibao CA. Morbidity and mortality in orthostatic hypotension. Auton Neurosci. 2020;229:102717.
Xin W, Lin Z, Mi S. Orthostatic hypotension and mortality risk: a meta-analysis of cohort studies. Heart. 2014;100(5):406-413.
Ricci F, Fedorowski A, Radico F, et al.; Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies. Eur Heart J. 2015;36(25):1609-1617.
Angelousi A, Girerd N, Benetos A, et al.; Association between orthostatic hypotension and cardiovascular risk, cerebrovascular risk, cognitive decline and falls as well as overall mortality: a systematic review and meta-analysis. J Hypertens. 2014;32(8):1562-1571.
Fedorowski A, Stavenow L, Hedblad B, et al.; Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project). Eur Heart J. 2010;31(1):85-91.
Rose KM, Eigenbrodt ML, Biga RL, et al.; Orthostatic hypotension predicts mortality in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) Study. Circulation. 2006;114(7):630-636.
Luukinen H, Koski K, Laippala P, et al.; Orthostatic hypotension and the risk of myocardial infarction in the home-dwelling elderly. J Intern Med. 2004;255(4):486-493.
Ooi WL, Hossain M, Lipsitz LA. The association between orthostatic hypotension and recurrent falls in nursing home residents. Am J Med. 2000;108(2):106-111.
Gaspar L, Kruzliak P, Komornikova A, et al.; Orthostatic hypotension in diabetic patients-10-year follow-up study. J Diabetes Complications. 2016;30(1):67-71.
van Hateren KJJ, Kleefstra N, Blanker MH, et al.; Orthostatic hypotension, diabetes, and falling in older patients: a cross-sectional study. Br J Gen Pract. 2012;62(603):e696-e702.
Spallone V, Ziegler D, Freeman R, et al; Toronto Consensus Panel on Diabetic Neuropathy; Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011;27(7):639-653.
Vinik AI, Erbas T, Casellini CM. Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease. J Diabetes Investig. 2013;4(1):4-18.
Zhou Y, Ke S-J, Qiu X-P, et al.; Prevalence, risk factors, and prognosis of orthostatic hypotension in diabetic patients: a systematic review and meta-analysis. Medicine (Baltimore). 2017;96(36):e8004.
Shibao C, Grijalva CG, Raj SR, et al.; Orthostatic hypotension-related hospitalizations in the United States. Am J Med. 2007;120(11):975-980.
Lanier JB, Mote MB, Clay EC. Evaluation and management of orthostatic hypotension. Am Fam Physician. 2011;84(5):527-536. Accessed September 13, 2021. https://www.aafp.org/afp/2011/0901/p527.html
Freeman R. Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med. 2008;358(6):615-624.
Palma J-A, Kaufmann H. Management of orthostatic hypotension. Continuum (Minneap Minn). 2020;26(1):154-177.
Kaufmann H, Norcliffe-Kaufmann L, Palma J-A. Baroreflex dysfunction. N Engl J Med. 2020;382(2):163-178.
Gibbons CH, Schmidt P, Biaggioni I, et al.; The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264(8):1567-1582.
Low PA. Neurogenic orthostatic hypotension: pathophysiology and diagnosis. Am J Manag Care. 2015;21(13 suppl):s248-s257.
Fanciulli A, Campese N, Wenning GK. The Schellong test: detecting orthostatic blood pressure and heart rate changes in German-speaking countries. Clin Auton Res. 2019;29(4):363-366.
Carlson JE. Assessment of orthostatic blood pressure: measurement technique and clinical applications. South Med J. 1999;92(2):167-173.
Cooke J, Carew S, O'Connor M, et al.; Sitting and standing blood pressure measurements are not accurate for the diagnosis of orthostatic hypotension. QJM. 2009;102(5):335-339.
Wieling W, Krediet CTP, van Dijk N, et al.; Initial orthostatic hypotension: review of a forgotten condition. Clin Sci (Lond). 2007;112(3):157-165.
Finucane C, O'Connell MDL, Donoghue O, et al.; Impaired orthostatic blood pressure recovery is associated with unexplained and injurious falls. J Am Geriatr Soc. 2017;65(3):474-482.
Gibbons CH, Freeman R. Clinical implications of delayed orthostatic hypotension: a 10-year follow-up study. Neurology. 2015;85(16):1362-1367.
Juraschek SP, Daya N, Rawlings AM, et al.; Association of history of dizziness and long-term adverse outcomes with early vs later orthostatic hypotension assessment times in middle-aged adults. JAMA Intern Med. 2017;177(9):1316-1323.
Lahrmann H, Cortelli P, Hilz M, et al.; EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol. 2006;13(9):930-936.
Norcliffe-Kaufmann L, Kaufmann H, Palma J-A, et al; Autonomic Disorders Consortium; Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies. Ann Neurol. 2018;83(3):522-531.
Cheshire WP, Goldstein DS. Autonomic uprising: the tilt table test in autonomic medicine. Clin Auton Res. 2019;29(2):215-230.
Sheldon RS, Grubb BP, Olshansky B, et al.; 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12(6):e41-e63.
Zadourian A, Doherty TA, Swiatkiewicz I, et al.; Postural orthostatic tachycardia syndrome: prevalence, pathophysiology, and management. Drugs. 2018;78(10):983-994.
Bryarly M, Phillips LT, Fu Q, et al.; Postural orthostatic tachycardia syndrome: JACC focus seminar. J Am Coll Cardiol. 2019;73(10):1207-1228.
Shen W-K, Sheldon RS, Benditt DG, et al.; 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society [published correction appears in Circulation. 2017;136(16):e269–e270]. Circulation. 2017;136(5):e25-e59.
Olshansky B, Cannom D, Fedorowski A, et al.; Postural orthostatic tachycardia syndrome (POTS): a critical assessment. Prog Cardiovasc Dis. 2020;63(3):263-270.
Stewart JM, Boris JR, Chelimsky G, et al; Pediatric Writing Group of the American Autonomic Society; Pediatric disorders of orthostatic intolerance. Pediatrics. 2018;141(1):e20171673.
Lamarre-Cliche M, Cusson J. The fainting patient: value of the head-upright tilt-table test in adult patients with orthostatic intolerance. CMAJ. 2001;164(3):372-376.
Jamnadas-Khoda J, Koshy S, Mathias CJ, et al.; Are current recommendations to diagnose orthostatic hypotension in Parkinson's disease satisfactory?. Mov Disord. 2009;24(12):1747-1751.
Aydin AE, Soysal P, Isik AT. Which is preferable for orthostatic hypotension diagnosis in older adults: active standing test or head-up tilt table test?. Clin Interv Aging. 2017;12:207-212.
Fanciulli A, Jordan J, Biaggioni I, et al.; Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH). Clin Auton Res. 2018;28(4):355-362.
Shibao C, Lipsitz LA, Biaggioni I; American Society of Hypertension Writing Group; Evaluation and treatment of orthostatic hypotension. J Am Soc Hypertens. 2013;7(4):317-324.
Subbarayan S, Myint PK, Martin KR, et al.; Nonpharmacologic management of orthostatic hypotension in older people: a systematic review. The SENATOR ONTOP Series. J Am Med Dir Assoc. 2019;20(9):1065-1073.e3.
Poon IO, Braun U. High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. J Clin Pharm Ther. 2005;30(2):173-178.
Hermida RC, Ayala DE, Mojón A, et al.; Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 2011;58(11):1165-1173.
Puvi-Rajasingham S, Mathias CJ. Effect of meal size on post-prandial blood pressure and on postural hypotension in primary autonomic failure. Clin Auton Res. 1996;6(2):111-114.
Carroll JF, Wood CE, Pollock ML, et al.; Hormonal responses in elders experiencing pre-syncopal symptoms during head-up tilt before and after exercise training. J Gerontol A Biol Sci Med Sci. 1995;50(6):M324-M329.
Loughlin EA, Judge CS, Gorey SE. Increased salt intake for orthostatic intolerance syndromes: a systematic review and meta-analysis. Am J Med. 2020;133(12):1471-1478.e4.
Newton JL, Frith J. The efficacy of nonpharmacologic intervention for orthostatic hypotension associated with aging. Neurology. 2018;91(7):e652-e656.
Henry R, Rowe J, O'Mahony D. Haemodynamic analysis of efficacy of compression hosiery in elderly fallers with orthostatic hypotension. Lancet. 1999;354(9172):45-46.
Fan CW, Walsh C, Cunningham CJ. The effect of sleeping with the head of the bed elevated six inches on elderly patients with orthostatic hypotension: an open randomised controlled trial. Age Ageing. 2011;40(2):187-192.
Low PA, Gilden JL, Freeman R, et al; Midodrine Study Group; Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study [published correction appears in JAMA. 1997; 278(5): 388]. JAMA. 1997;277(13):1046-1051.
Wright RA, Kaufmann HC, Perera R, et al.; A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology. 1998;51(1):120-124.
Jankovic J, Gilden JL, Hiner BC, et al.; Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med. 1993;95(1):38-48.
Kaufmann H, Freeman R, Biaggioni I, et al; NOH301 Investigators; Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology. 2014;83(4):328-335.
Schoffer KL, Henderson RD, O'Maley K, et al.; Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease. Mov Disord. 2007;22(11):1543-1549.
Ramirez CE, Okamoto LE, Arnold AC, et al.; Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. 2014;64(6):1235-1240.
Patel H, Simpson A, Palevoda G, et al.; Evaluating the effectiveness of atomoxetine for the treatment of primary orthostatic hypotension in adults. J Clin Hypertens (Greenwich). 2018;20(4):794-797.
Singer W, Sandroni P, Opfer-Gehrking TL, et al.; Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol. 2006;63(4):513-518.
McClellan KJ, Wiseman LR, Wilde MI. Midodrine. a review of its therapeutic use in the management of orthostatic hypotension. Drugs Aging. 1998;12(1):76-86.
Isaacson S, Shill HA, Vernino S, et al.; Safety and durability of effect with long-term, open-label droxidopa treatment in patients with symptomatic neurogenic orthostatic hypotension (NOH303). J Parkinsons Dis. 2016;6(4):751-759.
Eschlböck S, Wenning G, Fanciulli A. Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms [published correction appears in J Neural Transm (Vienna). 2018;125(2):273–274]. J Neural Transm (Vienna). 2017;124(12):1567-1605.
Hauser RA, Heritier S, Rowse GJ, et al.; Droxidopa and reduced falls in a trial of Parkinson disease patients with neurogenic orthostatic hypotension. Clin Neuropharmacol. 2016;39(5):220-226.
Grijalva CG, Biaggioni I, Griffin MR, et al.; Fludrocortisone is associated with a higher risk of all-cause hospitalizations compared with midodrine in patients with orthostatic hypotension. J Am Heart Assoc. 2017;6(10):e006848.
Okamoto LE, Shibao CA, Gamboa A, et al.; Synergistic pressor effect of atomoxetine and pyridostigmine in patients with neurogenic orthostatic hypotension. Hypertension. 2019;73(1):235-241.
Olshansky B, Muldowney J. Cardiovascular safety considerations in the treatment of neurogenic orthostatic hypotension. Am J Cardiol. 2020;125(10):1582-1593.
Bradley JG, Davis KA. Orthostatic hypotension. Am Fam Physician. 2003;68(12):2393-2398. Accessed September 13, 2021. https://www.aafp.org/afp/2003/1215/p2393.html